Practical guidelines for the use of NESP in treating renal anaemia.
Aljama
P
P
Bommer
J
J
Canaud
B
B
Carrera
F
F
Eckardt
K U
KU
Hörl
W H
WH
Krediet
R T
RT
Locatelli
F
F
Macdougall
I C
IC
Wikström
B
B
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068256:Darbepoetin alfa; D016903:Drug Monitoring; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D010530:Peritoneal Dialysis / Q000592:standards; D006435:Renal Dialysis / Q000592:standards
D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa